MedTrace Logo

Perioperative Smoking Cessation BUndle in a Tertiary Care Hospital - Can Turning Virtual Improve Outcomes?

NCT04487548 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2025-08-14

No results posted yet for this study

Summary

Smoking continues to be a burden to the healthcare system in Canada. It is well-known that smokers suffer more complications and higher risk of mortality after surgery than non-smokers. A quality improvement project at Royal Columbian Hospital recently showed that it is possible to implement a smoking cessation bundle for all current smokers during their preadmission clinic visit. However, due to the COVID-19 pandemic, much of the bundle was abandoned as it relied heavily on in-person interactions. The investigators wish to study the effect of a structured smoking cessation bundle, delivered remotely, on smoking cessation and postoperative complications. The aim is to determine the feasibility of giving the remotely delivered bundle to elective surgical patients before or around the time of a preadmission clinic visit, and whether it can reduce smoking rates and postoperative complications versus the standard uncoordinated advice.

Conditions

  • Smoking Cessation
  • Surgical Complications

Interventions

OTHER

Remote smoking cessation bundle

The bundle is a remote version of what has previously been described in prior literature, which includes: 1. A brief (\<5 minutes) advice 2. Preoperative smoking cessation video prepared by QuitNow 3. Patients will be provided brochures on smoking cessation 4. A referral will be faxed (or internet-registered) to the Quitnow.ca Smokers' Helpline 5. All patients will be requested to participate in the provincial Smoking Cessation program that provides a free 12-week supply of NRT once per year.

Sponsors & Collaborators

  • Royal Columbian Hospital Foundation

    collaborator OTHER

  • Fraser Health

    lead OTHER

Principal Investigators

  • Susan M Lee, MD, FRCPC · Fraser Health Authority

  • Michelle Mozel, MSc · Fraser Health Authority

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-02-24
Primary Completion
2023-12-06
Completion
2023-12-06

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04487548 on ClinicalTrials.gov